Selectie serotonin reuptake inhibitors inhibit platelet actiation and may, therefore, affect outcomes in patients with acute coronary syndromes.

• 因为选择性5-羟色胺再吸收抑制剂可抑制血小板激活，所以可能会影响急性冠脉综合征患者预后。